Owner Janssen Pharmaceutica NV

Inventors Player, Mark R.; Parks, Daniel J.; Parsons, William; Meegalla, Sanath K.; Illig, Carl R.; Ballentine, Shelley K.

Agent Shelston IP

Pub. Number AU-A-2009303581

PCT Pub. Number WO2010/045166

Priority 61/105,449 15.10.08 US

Filing date 13 October 2009

Wipo publication date 22 April 2010

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4188 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/437 (2006.01)

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms